1. Home
  2. BRCC vs CHRS Comparison

BRCC vs CHRS Comparison

Compare BRCC & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRCC
  • CHRS
  • Stock Information
  • Founded
  • BRCC 2014
  • CHRS 2010
  • Country
  • BRCC United States
  • CHRS United States
  • Employees
  • BRCC N/A
  • CHRS N/A
  • Industry
  • BRCC Beverages (Production/Distribution)
  • CHRS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BRCC Consumer Staples
  • CHRS Health Care
  • Exchange
  • BRCC Nasdaq
  • CHRS Nasdaq
  • Market Cap
  • BRCC 186.6M
  • CHRS 194.1M
  • IPO Year
  • BRCC N/A
  • CHRS 2014
  • Fundamental
  • Price
  • BRCC $1.34
  • CHRS $1.73
  • Analyst Decision
  • BRCC Strong Buy
  • CHRS Strong Buy
  • Analyst Count
  • BRCC 4
  • CHRS 4
  • Target Price
  • BRCC $2.75
  • CHRS $4.51
  • AVG Volume (30 Days)
  • BRCC 486.3K
  • CHRS 999.4K
  • Earning Date
  • BRCC 11-03-2025
  • CHRS 11-07-2025
  • Dividend Yield
  • BRCC N/A
  • CHRS N/A
  • EPS Growth
  • BRCC N/A
  • CHRS N/A
  • EPS
  • BRCC N/A
  • CHRS 1.55
  • Revenue
  • BRCC $388,893,000.00
  • CHRS $272,209,000.00
  • Revenue This Year
  • BRCC $3.98
  • CHRS N/A
  • Revenue Next Year
  • BRCC $12.08
  • CHRS $109.48
  • P/E Ratio
  • BRCC N/A
  • CHRS $1.12
  • Revenue Growth
  • BRCC N/A
  • CHRS 52.33
  • 52 Week Low
  • BRCC $1.19
  • CHRS $0.66
  • 52 Week High
  • BRCC $3.52
  • CHRS $2.43
  • Technical
  • Relative Strength Index (RSI)
  • BRCC 38.46
  • CHRS 56.93
  • Support Level
  • BRCC $1.33
  • CHRS $1.64
  • Resistance Level
  • BRCC $1.43
  • CHRS $1.75
  • Average True Range (ATR)
  • BRCC 0.05
  • CHRS 0.10
  • MACD
  • BRCC 0.00
  • CHRS -0.02
  • Stochastic Oscillator
  • BRCC 26.80
  • CHRS 51.84

About BRCC BRC Inc.

BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.

Share on Social Networks: